IE46152L - Ergot peptide alkaloid derivatives - Google Patents

Ergot peptide alkaloid derivatives

Info

Publication number
IE46152L
IE46152L IE771838A IE183877A IE46152L IE 46152 L IE46152 L IE 46152L IE 771838 A IE771838 A IE 771838A IE 183877 A IE183877 A IE 183877A IE 46152 L IE46152 L IE 46152L
Authority
IE
Ireland
Prior art keywords
hydrogen
alkaloid derivatives
alkyl
carbon atoms
ergot peptide
Prior art date
Application number
IE771838A
Other versions
IE46152B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128676A external-priority patent/CH623591A5/en
Priority claimed from CH1128776A external-priority patent/CH623592A5/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE46152L publication Critical patent/IE46152L/en
Publication of IE46152B1 publication Critical patent/IE46152B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ERGOT PEPTIDE ALKALOID DERIVATIVES Compounds of formula I, I wherein R1 is alkyl of 1 to 4 carbon atoms, R2 is hydrogen, alkyl of 1 to 4 carbon atoms or benzyl, R3 and R5 are, independently, hydrogen or methyl, R4 is hydrogen or alkyl of 1 to 4 carbon atoms, and R6 and R7 together form a single bond, or R6 and R7 are each hydrogen, R6 is methoxy, and R7 is hydrogen, are useful in the treatment of hypertension, angina pectoris, depressions, neuroses and psychoses. [CA1105007A]
IE1838/77A 1976-09-06 1977-09-05 Ergot peptide aklaloid derivatives IE46152B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives

Publications (2)

Publication Number Publication Date
IE46152L true IE46152L (en) 1978-03-06
IE46152B1 IE46152B1 (en) 1983-03-09

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1838/77A IE46152B1 (en) 1976-09-06 1977-09-05 Ergot peptide aklaloid derivatives

Country Status (15)

Country Link
JP (1) JPS5331698A (en)
AU (1) AU512027B2 (en)
CA (1) CA1105007A (en)
DE (1) DE2738730A1 (en)
DK (1) DK147390C (en)
ES (1) ES462080A1 (en)
FI (1) FI64942C (en)
FR (1) FR2363571A1 (en)
GB (2) GB1590149A (en)
IE (1) IE46152B1 (en)
IL (1) IL52896A (en)
NL (1) NL7709683A (en)
NZ (1) NZ185098A (en)
PT (1) PT67003B (en)
SE (1) SE435839B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103827113A (en) * 2011-06-23 2014-05-28 Map药物公司 Novel fluoroergoline analogs

Also Published As

Publication number Publication date
CA1105007A (en) 1981-07-14
JPS5331698A (en) 1978-03-25
FI64942C (en) 1984-02-10
ES462080A1 (en) 1978-12-01
PT67003A (en) 1977-10-01
SE435839B (en) 1984-10-22
DK147390C (en) 1985-02-04
SE7709645L (en) 1978-03-07
DK382777A (en) 1978-03-07
AU2857277A (en) 1979-03-15
FR2363571B1 (en) 1980-04-18
PT67003B (en) 1979-05-14
FR2363571A1 (en) 1978-03-31
FI64942B (en) 1983-10-31
IE46152B1 (en) 1983-03-09
DE2738730A1 (en) 1978-03-16
AU512027B2 (en) 1980-09-18
FI772557A (en) 1978-03-07
DK147390B (en) 1984-07-16
IL52896A0 (en) 1977-11-30
GB1590149A (en) 1981-05-28
NL7709683A (en) 1978-03-08
IL52896A (en) 1980-07-31
NZ185098A (en) 1980-04-28
GB1590150A (en) 1981-05-28

Similar Documents

Publication Publication Date Title
ES8206474A1 (en) Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids.
GR3020848T3 (en) 1,8-Naphthyridin-2-one derivatives
ES8701721A1 (en) 1,3,4,5-Tetrahydrobenzo(c,d)indoles, process for their preparation and their uses.
NZ514662A (en) Amine derivatives
ES476343A1 (en) Cyclopentan-1-amines
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
NO174257C (en) Analogous Process for Preparation of Therapeutically Active Imidazopyridazines
HUT47580A (en) Process for production of tricycle oxindole derivatives decreasing inflammation
ES2021182A6 (en) Capsaicin derivatives
IE802558L (en) Ergoline derivatives.
IE46152L (en) Ergot peptide alkaloid derivatives
DE3869163D1 (en) BENZYLIDENAMINO, BENZYLAMINO AND BENZOYLAMINO IMIDAZOLE DERIVATIVES.
IE893211L (en) Benzoxazepinone Process
GB2341861A (en) Substituted imidazole derivatives and their use as histamine H 3 receptor ligands
TW334428B (en) Novel benzodiazepine derivatives
AU3029089A (en) Process for preparing 2 beta-substituted-methylpenicillin derivatives
CA2053705A1 (en) Piperazine derivatives
EP0127196A3 (en) Antihypertensive lactams
MY103515A (en) Ergolinyl heterocycles
IE781354L (en) Amido-benzylpyrimidines
IE44403L (en) CIS-4a-PHENYL-ISOQUINOLINES
IE42638L (en) Phenyl - pyrrolidinyl pyridine derivatives
HUP9900923A2 (en) Process for the synthesis of vinyl-sulfenic acid derivatives
IL86665A0 (en) Mitomycin analogs
IE41481L (en) 1, 4-benzodiazepine derivatives.